Podcast

Riedel and Van Tine Spotlight Sarcoma Advances and Preview Ongoing Studies

Author(s):

Dr. Riedel and Dr. Van Tine discuss the multidisciplinary management of patients with sarcoma, the clinical impact of the FDA approval of ripretinib in the gastrointestinal stromal tumor paradigm, and other exciting advances in sarcoma.

Welcome to OncLive On AirTM! I’m your host today, Caroline Seymour.

OncLive On AirTM is a podcast from OncLive, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, sponsored by Deciphera Pharmaceuticals, Inc., we had the pleasure of speaking with Richard F. Riedel, MD, associate professor of medicine at Duke Cancer Institute, and Brian A. Van Tine, MD, PhD, associate professor in the Department of Medicine, director of the Sarcoma Program in the Division of Medical Oncology at Washington University School of Medicine in St. Louis, to discuss treatment gaps that have plagued the sarcoma field and research through which investigators are hoping to fill those gaps.

In our exclusive interview, Riedel and Van Tine discussed the multidisciplinary management of patients with sarcoma, the clinical impact of the FDA approval of ripretinib (Qinlock) in the gastrointestinal stromal tumor paradigm, and other exciting advances in sarcoma.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments
Video

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Apr 23rd 2025 - Apr 24th 2026

online-activity
Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2
Video

Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2

Apr 23rd 2025 - Apr 24th 2026

online-activity
Addressing Unmet Needs in HER2+ Metastatic BTC
Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 18th 2025 - Apr 19th 2026

online-activity